Diagram of reliability and net gain: A new method for summarizing and displaying the results of controlled trials

Pain Practice

Volumn 7, Issue 3, 2007, Pages 230-233

  Cruccu, Giorgio ^a   Taylor, Rod S ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Clinical guidelines; Evidence based policy; Pain therapy

Indexed keywords

CANNABIS; CAPSAICIN; GABAPENTIN; LAMOTRIGINE; LIDOCAINE; MEXILETINE; N METHYL DEXTRO ASPARTIC ACID; OPIATE; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SODIUM CHANNEL BLOCKING AGENT; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ARTICLE; CALCULATION; CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; EVIDENCE BASED PRACTICE; HUMAN; METHODOLOGY; NEUROPATHIC PAIN; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RISK BENEFIT ANALYSIS; SAMPLE SIZE;

ANALGESICS; DOUBLE-BLIND METHOD; HUMANS; PAIN; RANDOMIZED CONTROLLED TRIALS; SAMPLE SIZE;

EID: 34548092420     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2007.00131.x     Document Type: Article

References (8)

1. Sackett DL. Evidence-based medicine and treatment choices. Lancet. 1997; 349: 570.
2. Muir Gray JA, Haynes RB, Sackett DL, Cook DJ, Guyatt GH. Transferring evidence from research into practice: 3. Developing evidence-based clinical policy. ACP J Club. 1997; 126: A14-A16.
3. Muir Gray JA. Evidence based policy making. BMJ. 2004; 329: 988-989.
4. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain. 2005; 118: 289-305.
5. Attal N, Cruccu G, Haanpa M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006; 13: 1-17.
6. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004; 328: 1490-1498.
7. National Institute for Health and Clinical Excellence (NICE). The Guideline Development Process-An Overview for Stakeholders, the Public and the NHS. February 2004. Available at: http://www.nice.org.uk/ page.aspx?o=308639 (accessed September 13, 2006).
8. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials. 1996; 17: 1-12.